May 22, 2020 webinar: “Imaging SARS-COV-2 safely: Protecting the microscopy community”
As the SARS-COV-2 pandemic progresses, scientific focus will gradually shift from frontline testing and tracking capability to studying the fundamental cell biology of the virus and clinical progression of virus infection in human tissues. This webinar brings together expert microscopists and virologists who are studying inactivation of virus in cells and tissues for safe handling, imaging the cell biology of viruses and handling virus-infected human tissues.
The Francis Crick Institute is organizing a webinar “Imaging SARS-COV-2 safely: Protecting the microscopy community” that brings together expert pathologists, microscopists and virologists who are studying inactivation of virus in cells and tissues for safe handling, imaging the cell biology of viruses and handling virus-infected human tissues. Invited speakers will give short talks sharing their expertise, followed by a Q&A session to answer questions from the microscopy community.
When: May 22nd, 2020
Registration: https://crick.zoom.us/webinar/register/WN_AySOxJ0LTJOlFbQEW2c6DQ
Programme– please note these are London timings (+1hr CEST.-5 hrs ET). This webinar starts at 7 a.m. CT for the US.
13:00 – 13:10 Introduction and webinar etiquette
Lucy Collinson (Francis Crick Institute, London, UK)
13:10 – 13:30 Looking Covid in the eye: a perspective from an NHS histopathologist
Dr Emyr Wyn Benbow (University of Manchester/Manchester Royal Infirmary)
13:30 – 13:50 Virus Inactivation for Imaging-how to get images of SARS-CoV-2 without endangering yourself or the community.
Dr Matthew Hannah (Public Health England)
13:50 – 14:10 Imaging viruses in high containment research labs
Professor Pippa Hawes (The Pirbright Institute)
14:10 – 14:30 Understanding coronavirus replication organelles
Dr Helena Maier (The Pirbright Institute)
14:30 – 14:50 The virologist’s toolbox. An overview of methods to manipulate RNA viruses and cells for imaging.
Dr Rachel Ulferts (Francis Crick Institute)
14:50 – 16:00 Panel Discussion/ Q&A- All